Combination Chemotherapy
Showing 1 - 25 of >10,000
Melanoma Trial in Beijing (tunlametinib, paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin)
Not yet recruiting
- Melanoma
- tunlametinib
- paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Aug 15, 2023
Endometrial Carcinoma Trial in Sohag (Paclitaxel/epirubcin/carboplatin, Paclitaxel/carboplatin)
Not yet recruiting
- Endometrial Carcinoma
-
Sohag, EgyptSohag university Hospital
Oct 25, 2023
Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)
Not yet recruiting
- Pancreas Cancer
- Non-Resectable Pancreas Carcinoma
- Gemcitabine
- Nab paclitaxel
-
Aalborg, DenmarkDepartment of Oncology, Aalborg University Hospital
May 1, 2023
Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)
Not yet recruiting
- Serous Ovarian Cancer
- Advanced Ovarian Cancer
- SC0191
- +2 more
- (no location specified)
Sep 20, 2023
Solid Tumor Trial in Beijing (QLS31905, Nab paclitaxel, Gemcitabine)
Not yet recruiting
- Solid Tumor
- QLS31905
- +5 more
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Sep 10, 2023
Urothelial Carcinoma Associated 1 RNA, Human Trial (Pembrolizumab, Cisplatin, Carboplatin)
Active, not recruiting
- Urothelial Carcinoma Associated 1 RNA, Human
- Pembrolizumab
- +3 more
- (no location specified)
Aug 18, 2022
Risarg® Combined With Endocrine Therapy or Chemotherapy in
Not yet recruiting
- HR+HER2- Advanced Breast Cancer
- Ribociclib
- Combination chemotherapy
- (no location specified)
Nov 20, 2023
NSCLC Trial (Durvalumab, Tremelimumab, Pemetrexed)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Durvalumab
- +5 more
- (no location specified)
Aug 17, 2023
Gastric Cancer (Diagnosis) Trial (Modified Banxia Xiexin Decoction, combination chemo with Placebo granules)
Completed
- Gastric Cancer (Diagnosis)
- Modified Banxia Xiexin Decoction
- combination chemotherapy with Placebo granules
- (no location specified)
Jun 16, 2023
HER2-positive Colorectal Cancer, HER2-positive Biliary Tract Cancer Trial in Beijing (KN026, KN046, XELOX)
Not yet recruiting
- HER2-positive Colorectal Cancer
- HER2-positive Biliary Tract Cancer
- KN026
- +2 more
-
Beijing, State*, ChinaPeking University cancer hospital & institution
Aug 2, 2023
Colorectal Cancer, Metastatic Cancer Trial in Boulogne Billancourt (FOLFIRI regimen, fluorouracil, irinotecan HCl)
Withdrawn
- Colorectal Cancer
- Metastatic Cancer
- FOLFIRI regimen
- +7 more
-
Boulogne Billancourt, FranceHopital Ambroise Pare
Aug 26, 2022
Breast Cancer Trial in Worldwide (Docetaxel / Capecitabine, Capecitabine / Vinorelbine, Paclitaxel / Gemcitabine)
Active, not recruiting
- Breast Cancer
- Docetaxel / Capecitabine
- +5 more
-
Cairo, Egypt
- +51 more
Oct 24, 2022
Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Trial (Cadonilimab, AK117, Oxaliplatin)
Not yet recruiting
- Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
- Cadonilimab
- +5 more
- (no location specified)
Jul 17, 2023
Resectable Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy Trial (cadonilimab+chemo)
Not yet recruiting
- Resectable Esophageal Squamous Cell Carcinoma
- Neoadjuvant Therapy
- (no location specified)
Apr 18, 2023
Esophageal Cancer by AJCC V8 Stage Trial in Zhengzhou (Camrelizumab+Apatinib+Chemotherapy?Camrelizumab+Apatinib,
Recruiting
- Esophageal Cancer by AJCC V8 Stage
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Feb 12, 2023
Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (Nab paclitaxel, Carboplatin, adelbelimumab)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Nab paclitaxel
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital
Aug 24, 2023
Endometrial Cancer Trial in Copenhagen (Nintedanib or Placebo; Carboplatin, Paclitaxel)
Completed
- Endometrial Cancer
- Nintedanib or Placebo; Carboplatin, Paclitaxel
-
Copenhagen, Sjaelland, DenmarkNSGO
Jan 7, 2022
TNBC - Triple-Negative Breast Cancer Trial (Camrelizumab Plus Chemotherapy and Famitinib, Camrelizumab Plus Chemotherapy)
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- Camrelizumab Plus Chemotherapy and Famitinib
- Camrelizumab Plus Chemotherapy
- (no location specified)
Aug 17, 2023
Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- Propranolol
- Propranolol hydrochloride
- +2 more
- (no location specified)
Jul 31, 2023
GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)
Recruiting
- GastroEsophageal Cancer
- Gastric Cancer
- Neratinib
- +4 more
-
Tampa, FloridaMoffitt Cancer Center
Oct 25, 2023
Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Doxorubicin, Vincristine)
Active, not recruiting
- Hodgkin Lymphoma
- Brentuximab Vedotin
- +3 more
-
Valhalla, New YorkNew York Medical College
Sep 27, 2022
Sintilimab and Anlotinib in Combination With Chemo Trial in Xi'an (Sintilimab and anlotinib in combination with chemo)
Completed
- Sintilimab and Anlotinib in Combination With Chemotherapy
- Sintilimab and anlotinib in combination with chemotherapy
-
Xi'an, Shanxi, China
- +1 more
Aug 27, 2023
Hepatocellular Carcinoma Trial in Nanjing, Shanghai (QL1706, Bevacizumab, Oxaliplatin injection)
Not yet recruiting
- Hepatocellular Carcinoma
- QL1706
- +4 more
-
Nanjing, Jiangsu, China
- +1 more
Jul 28, 2023